Ontology highlight
ABSTRACT:
SUBMITTER: Capelli D
PROVIDER: S-EPMC10136296 | biostudies-literature | 2023 Apr
REPOSITORIES: biostudies-literature
Capelli Davide D Cazzaniga Giulia G Mori Matteo M Laghezza Antonio A Loiodice Fulvio F Quaglia Martina M Negro Elisa E Meneghetti Fiorella F Villa Stefania S Montanari Roberta R
Biomolecules 20230419 4
PPARγ represents a key target for the treatment of type 2 diabetes and metabolic syndrome. To avoid serious adverse effects related to the PPARγ agonism profile of traditional antidiabetic drugs, a new opportunity is represented by the development of molecules acting as inhibitors of PPARγ phosphorylation by the cyclin-dependent kinase 5 (CDK5). Their mechanism of action is mediated by the stabilization of the PPARγ β-sheet containing Ser273 (Ser245 in PPARγ isoform 1 nomenclature). In this pape ...[more]